Skip to content
value.today

Pathology Holdings, Inc.

🇺🇸 Torrance, California, USAHealth CareFounded 2009
Total raised
$30 M
2 rounds on record
Latest round
$21 M
Nov 2011
First round on record
Dec 2010
Today
Private
No later event on record

Funding rounds

2 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Pathology Holdings, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2011$21 MNo. 2$10 to $50 million

Pathology Holdings, Inc.: Raise no. 2, Nov 2011

Investors in this round

19 investors had bought by the notice of Dec 5, 2011: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$21 M of $21 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Steve Pierce · Executive Officer
  • Vicki DiFrancesco · Executive Officer, Director
  • Alfred Lui, M.D. · Director
  • Jerrold Glick · Director
  • John Stobo · Director
  • Mark Anderson · Director
  • Timothy Johnson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Vicki DiFrancesco, President. Source: SEC Form D, newest notice filed Dec 5, 2011. Read the notice at the SEC.

equitySEC
Dec 2010$9 MNo. 1$2 to $10 million

Pathology Holdings, Inc.: Raise no. 1, Dec 2010

Investors in this round

12 investors had bought by the notice of Jan 12, 2011: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $9 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Steve Pierce · Executive Officer
  • Vicki DiFrancesco · Executive Officer, Director
  • Alfred Lui, M.D. · Director
  • Jerrold Glick · Director
  • John Stobo · Director
  • Mark Anderson · Director
  • Timothy Johnson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Vicki DiFrancesco, President. Source: SEC Form D, newest notice filed Jan 12, 2011. Read the notice at the SEC.

equitySEC
Oct 2009$25 MIssued in a merger or acquisition$10 to $50 million

Pathology Holdings, Inc.: Private sale, Oct 2009

Investors in this round

12 investors had bought by the notice of Mar 11, 2010: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$25 M of $25 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Steve Pierce · Executive Officer
  • Vicki DiFrancesco · Executive Officer, Director
  • Alfred Lui, M.D. · Director
  • John Stobo · Director
  • Mark Anderson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On a merger: “The securities were sold in connection with the acquisition of Pathology Inc., a Medical Corporation”

Signed by Vicki DiFrancesco, President and CEO. Source: SEC Form D and 1 amendment, newest notice filed Mar 11, 2010. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Pathology Holdings, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2011).

    SEC Form D · Dec 2011

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Dec 2011

That is all the official record says: Pathology Holdings, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Pathology Holdings, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 19 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Pathology Holdings, Inc.
NameRoleNamed in
Steve PierceExecutive officerDec 2011
Vicki DiFrancescoExecutive officerDec 2011
Alfred Lui, M.D.DirectorDec 2011
Jerrold GlickDirectorDec 2011
John StoboDirectorDec 2011
Mark AndersonDirectorDec 2011
Timothy JohnsonDirectorDec 2011
Vicki DiFrancescoDirectorDec 2011